Risk factors for bleeding in haemato-oncology patients—a nested case–control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained)

INTRODUCTION: Haemato-oncological patients often receive platelet count driven prophylactic platelet transfusions to prevent bleeding. However, many prophylactically transfused patients still bleed. More knowledge on risk factors for bleeding is therefore needed. This will enable identification of b...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMJ Open
Hoofdauteurs: Cornelissen, Loes L, Caram-Deelder, Camila, van der Bom, Johanna G, Middelburg, Rutger A, Zwaginga, Jaap Jan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2020
Onderwerpen:
Oncology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7328810/
https://ncbi.nlm.nih.gov/pubmed/32606056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-034710
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items